Related Experiment Video
Updated: Jun 15, 2026

06:19
A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis
Published on: January 7, 2018
HIF-mediated hypoxic response is missing in severely hypoxic uterine leiomyomas
Arnulf Mayer1, Michael Hoeckel, Angelika von Wallbrunn
1Institute of Physiology and Pathophysiology, University Medical Center, Mainz, Germany. arnmayer@uni-mainz.de
Advances in Experimental Medicine and Biology
|March 6, 2010
Summary
Uterine leiomyomas are severely hypoxic but do not activate hypoxia-inducible factors (HIFs). This suggests HIF activation in solid tumors is linked to malignancy, not just hypoxia.
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Background:
- A direct link between tumor hypoxia and HIF-mediated protein expression is questioned in cervical cancers.
- Hypoxia-inducible factors (HIFs) are key regulators of cellular response to low oxygen.
- Understanding HIF regulation in benign vs. malignant tumors is crucial for cancer research.
Purpose of the Study:
- To investigate HIF-related marker expression in benign uterine leiomyomas under hypoxic conditions.
- To compare HIF pathway activation in leiomyomas versus leiomyosarcomas and normal myometrium.
- To determine if hypoxia uniformly induces HIFs in non-cancerous uterine tissue.
Main Methods:
- Immunohistochemistry, Western blotting, and RT-PCR were used to analyze HIF markers.
- Intraoperative polarographic needle electrode measurements assessed tumor oxygenation.
- Expression of HIF-1alpha, HIF-2alpha, GLUT-1, CA IX, PHD2, and PHD3 was quantified.
Main Results:
- Uterine leiomyomas exhibited severe, uniform hypoxia but lacked HIF-1alpha, HIF-2alpha, GLUT-1, and CA IX induction.
- Hypoxia-inducible prolyl hydroxylase domain proteins (PHDs) 2 and 3 were not overexpressed in leiomyomas.
- Leiomyomas showed reduced vascularization compared to normal myometrium, while leiomyosarcomas displayed robust HIF marker expression.
Conclusions:
- Severe hypoxia in uterine leiomyomas does not trigger canonical HIF pathway activation.
- The strong HIF system activation seen in malignant tumors may be tied to the transformed cellular phenotype.
- HIF activation appears to be a feature of malignancy rather than a general response to pathological hypoxia.
Related Concept Videos
Hypoxia
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Uterine Tubes
The uterine or fallopian tubes function as the conduit through which oocytes travel from the ovaries to the uterus. Each fallopian tube measures approximately 10 to 13 cm long and is anatomically divided into the infundibulum, ampulla, isthmus, and interstitial part (or intramural segment). The infundibulum is characterized by its funnel shape and features extensions called fimbriae which reach towards the peritoneal cavity. These fimbriae play a critical role during ovulation as they extend...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
